MGH Research Institute

Ended: Nov. 16, 2020

A Practical Guide to Leveraging the Mass General Brigham Biobank for Genetic and Biomarker Research
Monday, November 16 | 2:00-5:00pm | Zoom

Recent years have seen the rise of precision medicine as an organizing framework for biomedical research. Mass General Brigham has emerged as a leader in this new paradigm, facilitated in part by the availability of the Mass General Brigham (MGB) Biobank. With more than 120,000 participants enrolled and broad clinical data, biospecimens, and genomic data, the MGB Biobank offers a powerful resource for basic, clinical/translational, omics, and biomarker research.
The MGH Division of Clinical Research is sponsoring a mini-course focused on how investigators may leverage the MGB Biobank for genetic and biomarker research. Distinguished MGB faculty will provide an overview of the Biobank resource and examples of how investigators have used the biobank for discovery and biomarker research.

2:00-2:30 Welcome and Introduction to the Mass General Brigham Biobank
Jordan Smoller, MD, ScD, Director, Omics Unit, MGH Division of Clinical Research
2:30-3:00 Dynamic Genomics Research in the Mass General Brigham Biobank
Pradeep Natarajan, MD, MMSc, Director Preventive Cardiology, MGH
3:00-3:45 Development of Sex-Dependent Clinical Risk Algorithm for Alzheimer's disease in Early Midlife
Jill Goldstein, Ph.D. Executive Director, Innovation Center on Sex Differences in Medicine, MGH; Professor of Psychiatry & Medicine, HMS
3:45-4:00 Break
4:00-4:45 Epidemiologic, Biomarker, and Multi-Omics Approaches to Investigating Rheumatoid Arthritis Susceptibility and Outcomes
Jeffrey Sparks, MD, MMSc, Assistant Professor of Medicine, Director of Immuno-Oncology and Autoimmunity, BWH and HMS
4:45-5:00 Wrap Up Q&A

---

Category: Clinical Research

Sponsor: MGH Division of Clinical Research